Clinical Trial Update: Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress [Phase 4]

View source ↗

Summary

Phase 4 trial comparing efavirenz versus rilpivirine assessing vascular function, inflammation, and oxidative stress in cardiovascular disease; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• EFAVIRENZ (efavirenz)
• rilpivirine (rilpivirine)

Snippet

Sponsor: Indiana University | Conditions: Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-07-02